Trials / Completed
CompletedNCT05340855
A Pilot Study Using Facebook to Support Opioid Recovery Among American Indian Women
Facebook Intervention for Preventing Opioid Relapse Among American Indian Women: Wiidookaage'Win Pilot Preparatory Study (Aim 1)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to develop a culturally relevant Facebook intervention for American Indian and Alaska Native (AIAN) women in Minnesota recovering from illicit opioid use.
Detailed description
This one-year, Phase I, pilot preparatory study aims to develop a culturally relevant Facebook intervention for American Indian and Alaska Native (AIAN) women in Minnesota recovering from illicit opioid use. The study will consist of three phases: (1) qualitative interviews, (2) intervention content refinement and a moderator exchange (i.e., bi-directional sharing of knowledge between intervention moderators and trainers), and (3) a beta-testing period. A study-specific Community Advisory Committee (CAC) was formed whose members contributed to the study protocol and will continue to provide guidance and input on the study implementation and dissemination. At the advice of the CAC, a Native Elder woman named the study. Wiidookaage'win is an Ojibwe word that means "the place for help and time for helping," and reflects healing and community. The investigators expect the participatory approach to treatment development will result in a social media intervention with cultural relevance for Native women to maintain recovery from opioid use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Wiidookaage'win Facebook Group | A 30-day Facebook group prototype that is moderated by two women who will post various forms of media addressing opioid recovery, mindfulness, stress management, and resiliency. |
Timeline
- Start date
- 2022-05-05
- Primary completion
- 2023-06-08
- Completion
- 2023-06-08
- First posted
- 2022-04-22
- Last updated
- 2024-06-20
- Results posted
- 2024-06-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05340855. Inclusion in this directory is not an endorsement.